These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38425118)

  • 1. Diabetes and its Complications: Role of Luteolin, A Wonder Chemical from the Natural Source.
    Pradhan G; Kulkarni YA
    Curr Diabetes Rev; 2024 Feb; ():. PubMed ID: 38425118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution and biological activities of the flavonoid luteolin.
    López-Lázaro M
    Mini Rev Med Chem; 2009 Jan; 9(1):31-59. PubMed ID: 19149659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunopharmacological Activities of Luteolin in Chronic Diseases.
    Huang L; Kim MY; Cho JY
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses.
    Li L; Luo W; Qian Y; Zhu W; Qian J; Li J; Jin Y; Xu X; Liang G
    Phytomedicine; 2019 Jun; 59():152774. PubMed ID: 31009852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural Flavonoids as Potential Therapeutics in the Management of Diabetic Wound: A Review.
    Chanu NR; Gogoi P; Barbhuiya PA; Dutta PP; Pathak MP; Sen S
    Curr Top Med Chem; 2023; 23(8):690-710. PubMed ID: 37114791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luteolin as an anti-inflammatory and neuroprotective agent: A brief review.
    Nabavi SF; Braidy N; Gortzi O; Sobarzo-Sanchez E; Daglia M; Skalicka-Woźniak K; Nabavi SM
    Brain Res Bull; 2015 Oct; 119(Pt A):1-11. PubMed ID: 26361743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoformulations of flavonoids for diabetes and microvascular diabetic complications.
    Agarawal K; Anant Kulkarni Y; Wairkar S
    Drug Deliv Transl Res; 2023 Jan; 13(1):18-36. PubMed ID: 35637334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Updates on Source, Biosynthesis, and Therapeutic Potential of Natural Flavonoid Luteolin: A Review.
    Muruganathan N; Dhanapal AR; Baskar V; Muthuramalingam P; Selvaraj D; Aara H; Shiek Abdullah MZ; Sivanesan I
    Metabolites; 2022 Nov; 12(11):. PubMed ID: 36422285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor Activity of Luteolin Against Ehrlich Solid Carcinoma in Rats via Blocking Wnt/β-Catenin/SMAD4 Pathway.
    Aljohani H; Khodier AE; Al-Gayyar MM
    Cureus; 2023 May; 15(5):e39789. PubMed ID: 37265908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protective effects of flavonoids and carotenoids against diabetic complications-A review of
    Jin Y; Arroo R
    Front Nutr; 2023; 10():1020950. PubMed ID: 37032781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flavonoids as Potential Therapeutic Agents for the Management of Diabetic Neuropathy.
    Sood A; Kumar B; Singh SK; Prashar P; Gautam A; Gulati M; Pandey NK; Melkani I; Awasthi A; Saraf SA; Vidari G; Ozdemir M; Hussain FHS; Anwar ET; Ameen MSM; Gupta S; Porwal O
    Curr Pharm Des; 2020; 26(42):5468-5487. PubMed ID: 32851955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactive Compounds Effective Against Type 2 Diabetes Mellitus: A Systematic Review.
    Egbuna C; Awuchi CG; Kushwaha G; Rudrapal M; Patrick-Iwuanyanwu KC; Singh O; Odoh UE; Khan J; Jeevanandam J; Kumarasamy S; Chukwube VO; Narayanan M; Palai S; Găman MA; Uche CZ; Ogaji DS; Ezeofor NJ; Mtewa AG; Patrick-Iwuanyanwu CC; Kesh SS; Shivamallu C; Saravanan K; Tijjani H; Akram M; Ifemeje JC; Olisah MC; Chikwendu CJ
    Curr Top Med Chem; 2021; 21(12):1067-1095. PubMed ID: 33966619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luteolin, a flavonoid with potential for cancer prevention and therapy.
    Lin Y; Shi R; Wang X; Shen HM
    Curr Cancer Drug Targets; 2008 Nov; 8(7):634-46. PubMed ID: 18991571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of Luteolin in Neoplasms and Nonneoplastic Diseases.
    Rakoczy K; Kaczor J; Sołtyk A; Szymańska N; Stecko J; Sleziak J; Kulbacka J; Baczyńska D
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luteolin attenuates diabetes-associated cognitive decline in rats.
    Liu Y; Tian X; Gou L; Sun L; Ling X; Yin X
    Brain Res Bull; 2013 May; 94():23-9. PubMed ID: 23415807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Anti-Nociceptive and Anti-Inflammatory Effect of Luteolin in Mice.
    Fan X; Du K; Li N; Zheng Z; Qin Y; Liu J; Sun R; Su Y
    J Environ Pathol Toxicol Oncol; 2018; 37(4):351-364. PubMed ID: 30806241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidiabetic effect of flavonoid from
    Al-Masri AA; Ameen F; Davella R; Mamidala E
    Biotechnol Genet Eng Rev; 2023 May; ():1-16. PubMed ID: 37191034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of C-glycosylation of luteolin on its antioxidant, anti-Alzheimer's disease, anti-diabetic, and anti-inflammatory activities.
    Choi JS; Islam MN; Ali MY; Kim YM; Park HJ; Sohn HS; Jung HA
    Arch Pharm Res; 2014 Oct; 37(10):1354-63. PubMed ID: 24988985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tannins and vascular complications of Diabetes: An update.
    Laddha AP; Kulkarni YA
    Phytomedicine; 2019 Mar; 56():229-245. PubMed ID: 30668344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteolin improves the impaired nerve functions in diabetic neuropathy: behavioral and biochemical evidences.
    Li M; Li Q; Zhao Q; Zhang J; Lin J
    Int J Clin Exp Pathol; 2015; 8(9):10112-20. PubMed ID: 26617718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.